CTRI/2023/04/051951尚未招募4 期
An open label, single arm, multicenter, prospective study to evaluate safety and effectiveness of Akynzeo® I.V. [Fosnetupitant 235 mg and Palonosetron 0.25 mg (concentrate for solution for infusion)], in the prevention of chemotherapy induced nausea and vomiting (CINV) in Indian patients (STOP-CINV study) - STOP-CINV
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patient is scheduled to receive their first chemotherapy cycle of a highly
- •emetogenic or a moderately emetogenic chemotherapy (HEC/MEC).
- •2. Male/female patients aged above more than or equal to 18 years to less than or equal to 75 years
- •3. Willing to be part of study and for follow up.
- •4. Willing to provide written informed consent form.
排除标准
- •1. Patients with serious cardiovascular disease history or predisposition to
- •cardiac conduction abnormalities or use of medication which can cause
- •conduction abnormalities as per treating physicians’ assessment.
- •2. Vomiting, retching, or more than no significant nausea within 24 h before
- •the informed consent.
- •3. Women of child bearing potential who are pregnant, planning to becoming
- •pregnant or breast feeding.
- •4. Known contraindication to the intravenous administration of 50 mL 5%
- •glucose solution prior to index date
- •5. Hypersensitivity to active substances or excipients of Akynzeo® I.V.
- •6. Patient currently enrolled in another clinical trial.
- •7. Patients requiring multi-day chemotherapy
- •8. Patients who are prescribed other NK1RA and 5 HT3 RA
研究者
相似试验
尚未招募
Unknown
A clinical study to evaluate the effect of a test product (Meal Replacement Supplement) on weight management in overweight / obese patients.CTRI/2024/04/065016Dr. Reddys Laboratories Ltd.
招募中
不适用
utrition supplement for tube feeding assessed in hospitalized (ICU Stay) patientsCTRI/2022/12/047818Dr Reddys Laboratories
招募中
Unknown
A prospective study to evaluate the safety and the efficacy of blood pressure reduction of Laparoscopic RDN in patients with resistant hypertensioDiseases of the circulatory systemKCT0009209DeepQure10
进行中（未招募）
2 期
A Japanese Phase 2 study of 177Lu-PSMA-617 in participants with PSMA(+) mCRPCProstate CancerJPRN-jRCT2041210123Kazuyuki Suzuki28
进行中（未招募）
4 期
A study to evaluate the safety and efficacy of Nutricharge Glycem Tablet administered with Nutricharge Glycem Prodiet in Pre-diabetic subjectsCTRI/2017/10/010007Trophic Wellness Private Limited